Vietnam Diagnostic Tests Market Report and Forecast 2026-2034

Study Period

2021-2034

Market (2026)

USD 1.98 Billion

Market (2034)

USD 3.92 Billion

CAGR

8.9%

Major Markets Players

Bio-Rad Laboratories, Inc., Viet A Corporation, Abbott Laboratories GmbH (Vietnam), Thermo Fisher Scientific (Vietnam), Siemens Healthcare Limited Company and Others

*Note: Partial List Randomly Ordered

Vietnam Diagnostic Tests Market Key Highlights

Vietnam Diagnostic Tests Market Insights & Analysis

The Vietnam Diagnostic Tests Market is anticipated to register a CAGR of around 8.9% during the forecast period of 2026-2034. The market size is valued at USD 1.98 billion in 2026 and is projected to reach USD 3.92 billion by 2034. Vietnam's healthcare sector continues to strengthen its diagnostic capacity as hospitals, independent laboratories, and specialized testing centers invest in advanced technologies to improve disease detection and clinical outcomes. Rising cases of diabetes, cardiovascular disorders, cancer, respiratory illnesses, and infectious diseases have significantly increased the demand for laboratory testing across every level of healthcare. Molecular diagnostics, immunoassays, hematology, microbiology, and clinical chemistry testing have become routine components of patient management, while preventive health screening programs are encouraging earlier diagnosis. Private healthcare providers are also expanding laboratory networks to meet growing demand for high-quality diagnostic services and faster reporting times.

Continuous investment in laboratory automation, digital pathology, laboratory information management systems, and precision medicine is reshaping Vietnam's diagnostic landscape. Leading international manufacturers are strengthening their local operations through technology partnerships, product launches, and service expansion, while domestic companies continue increasing production of diagnostic consumables and laboratory solutions. Public hospitals are modernizing diagnostic infrastructure to improve testing capacity for oncology, infectious diseases, and chronic disease management. Recent deployments of advanced imaging and diagnostic technologies within major hospitals further support integrated disease diagnosis by improving clinical decision-making and increasing the need for confirmatory laboratory testing. These developments are expected to sustain long-term market growth as Vietnam continues improving healthcare accessibility, laboratory quality standards, and diagnostic capabilities throughout the forecast period.

Vietnam Diagnostic Tests Market Impact Analysis

Vietnam Diagnostic Tests Market Dynamics

Key Driver: Rising disease burden continues to increase laboratory testing volumes

Vietnam's changing disease profile has made diagnostic testing an essential part of routine healthcare delivery. Chronic conditions such as diabetes, cardiovascular disease, chronic kidney disease, and cancer require regular laboratory monitoring, while infectious diseases including dengue fever, tuberculosis, hepatitis, influenza, and respiratory infections continue to generate high testing demand. Earlier diagnosis has become a clinical priority because timely laboratory results improve treatment decisions, reduce complications, and support better patient outcomes. Healthcare providers are therefore expanding testing capacity across hospitals, clinics, and independent diagnostic laboratories to accommodate growing patient volumes.

Routine health examinations are becoming more common among urban populations, creating additional demand for blood chemistry, hematology, immunoassay, and molecular diagnostic tests. Expansion of health insurance coverage and improved access to healthcare services have also increased the utilization of laboratory diagnostics across public and private facilities. Investments in automated analyzers and high-throughput laboratory systems are enabling healthcare institutions to process larger testing volumes while maintaining consistent quality, supporting sustainable growth across Vietnam's diagnostic testing industry.

Industry Trend: Advanced molecular diagnostics and laboratory automation are transforming clinical testing

Clinical laboratories throughout Vietnam are steadily adopting advanced molecular diagnostic technologies to improve the speed and accuracy of disease detection. PCR, NAAT, fluorescence in situ hybridization, and next-generation sequencing are increasingly used for oncology, infectious disease surveillance, genetic disorder screening, and personalized treatment planning. These technologies enable clinicians to identify diseases at earlier stages while supporting more targeted therapeutic decisions. Their expanding clinical applications continue to strengthen demand for sophisticated diagnostic testing services.

Laboratory modernization is progressing alongside digital transformation initiatives across both public and private healthcare institutions. Automated sample preparation, integrated laboratory information systems, robotic analyzers, and digital reporting platforms are improving operational efficiency while reducing manual processing errors. Private hospital groups and independent laboratories are making substantial investments in automation to shorten turnaround times, improve productivity, and deliver more reliable diagnostic services, positioning Vietnam's laboratory sector for continued technological advancement.

Major Challenge: Uneven laboratory infrastructure limits nationwide access to advanced diagnostics

Although Vietnam has made notable progress in healthcare modernization, access to advanced diagnostic technologies remains concentrated within major cities. Large referral hospitals possess sophisticated molecular laboratories and automated testing platforms, while many provincial and district healthcare facilities continue operating with limited laboratory resources. Differences in equipment availability, technical expertise, and diagnostic capacity can affect the timely diagnosis of complex diseases, particularly in remote areas where access to specialized laboratory services remains constrained.

High acquisition costs for molecular analyzers, laboratory automation systems, and specialized reagents also create financial challenges for smaller healthcare providers. Maintaining quality management systems, ensuring regular equipment calibration, and recruiting experienced laboratory professionals require continuous investment. Addressing these structural challenges through infrastructure development, workforce training, and expanded laboratory accreditation programs will remain essential for improving equitable access to diagnostic services throughout Vietnam.

Opportunity: Precision medicine and healthcare modernization create new growth avenues

Vietnam's long-term healthcare development strategy is creating favorable conditions for the expansion of advanced diagnostic services. Hospitals are strengthening specialized clinical departments dedicated to oncology, cardiology, reproductive medicine, and rare diseases, increasing demand for companion diagnostics, biomarker testing, and genomic analysis. These services are becoming increasingly important as clinicians adopt more personalized treatment approaches supported by accurate laboratory evidence.

Investment from multinational healthcare companies, expansion of private diagnostic laboratory networks, and ongoing modernization of public hospitals are expected to accelerate technology adoption over the coming years. Home-based sample collection, point-of-care diagnostics, and integrated digital laboratory services are also expanding across urban healthcare markets, providing patients with faster access to testing while improving clinical efficiency. Continued improvements in laboratory quality standards and diagnostic infrastructure are expected to support sustained market expansion through 2034.

Vietnam Diagnostic Tests Market Segment-wise Analysis

By Test Type:

• Molecular Diagnostic Tests (PCR, NAAT, FISH, NGS)
• Coagulation Tests
• Immunoassay-based Diagnostic Tests
• Microbiology & Culture-based Tests
• Clinical Chemistry Tests
• Hematology Tests
• Others

Immunoassay-based Diagnostic Tests accounted for approximately 27.8% of the Vietnam Diagnostic Tests Market in 2026, making them the largest test type segment. Their widespread use across hospitals, independent laboratories, and diagnostic centers reflects their ability to deliver accurate and high-throughput testing for infectious diseases, endocrine disorders, cardiac conditions, oncology biomarkers, and autoimmune diseases. Healthcare providers continue to rely on automated immunoassay platforms because they provide rapid processing, high analytical sensitivity, and consistent results, making them suitable for routine clinical diagnostics and preventive health screening.

The segment is further supported by Vietnam's growing burden of chronic diseases and continuous expansion of national screening programs for hepatitis, HIV, thyroid disorders, and maternal health. Public and private laboratories are increasing investments in fully automated immunoassay analyzers to improve laboratory efficiency and reduce turnaround time. Continuous product innovation by global diagnostic manufacturers and greater availability of advanced reagent kits are expected to strengthen the adoption of immunoassay testing across both urban hospitals and regional healthcare facilities during the forecast period.

By End User:

• Research & Academic Laboratories
• Public Health & Government Laboratories
• Home Care & Self-testing (POCT-based Use)
• Clinics & Physician Offices
• Independent Diagnostic Laboratories
• Hospital-based Laboratories (Public & Private Hospitals)

Hospital-based Laboratories (Public & Private Hospitals) represented nearly 42.5% of total market revenue, maintaining their position as the leading end-user segment. Most diagnostic procedures in Vietnam are performed within hospital laboratories due to the availability of multidisciplinary clinical services, specialized physicians, and integrated patient care. Large tertiary hospitals routinely conduct clinical chemistry, hematology, microbiology, immunology, molecular diagnostics, and pathology testing, allowing clinicians to make timely treatment decisions across a broad range of medical specialties.

Ongoing investments in laboratory automation, digital laboratory information systems, and advanced diagnostic equipment continue to strengthen hospital testing capabilities. Major public hospitals are expanding laboratory capacity to accommodate increasing patient volumes, while private healthcare providers are investing in premium diagnostic services to enhance patient experience and clinical outcomes. Rising hospital admissions associated with cancer, cardiovascular disease, diabetes, and infectious diseases are expected to sustain the dominance of hospital-based laboratories throughout the forecast period.

Regional Projection of Vietnam Diagnostic Tests Industry

• Northern Vietnam
• Central Vietnam
• Southern Vietnam
• Others

Southern Vietnam accounted for approximately 46.3% of the Vietnam Diagnostic Tests Market, supported by its well-developed healthcare infrastructure and concentration of advanced medical institutions. Ho Chi Minh City serves as the country's largest healthcare and life sciences hub, housing leading public hospitals, private healthcare groups, specialized diagnostic laboratories, and biotechnology companies. The region benefits from higher healthcare expenditure, greater insurance coverage, and stronger private-sector participation, creating favorable conditions for the adoption of advanced laboratory technologies and precision diagnostic services.

Healthcare providers across Southern Vietnam continue expanding laboratory infrastructure through investments in molecular diagnostics, laboratory automation, digital pathology, and high-capacity testing platforms. The region also attracts significant investment from international diagnostic companies, resulting in wider availability of innovative testing solutions and technical expertise. Increasing demand for early disease detection, preventive health screening, and specialized diagnostic services for oncology, infectious diseases, and chronic disorders is expected to reinforce Southern Vietnam's leadership position throughout the 2026-2034 forecast period.

Vietnam Diagnostic Tests Market Regional Analysis

Vietnam’s diagnostic market varies by region due to hospital concentration, income gaps, and access to care.

Government Initiatives & Policies

• National Digital Health Program (2025-2030): Vietnam's Ministry of Health continues expanding digital healthcare infrastructure by integrating electronic medical records, laboratory information systems, and interoperable health databases to improve diagnostic accuracy, patient management, and nationwide healthcare efficiency.
• Circular on Quality Management of Medical Laboratories (2025 Implementation): The Ministry of Health continues strengthening laboratory quality standards through nationwide implementation of standardized quality management systems, accreditation practices, and laboratory result harmonization to improve reliability and patient safety across diagnostic facilities.

Vietnam Diagnostic Tests Industry Recent Developments

• 2025: Siemens Healthineers installed its first NAEOTOM Alpha photon-counting CT system at Phuong Dong General Hospital, strengthening Vietnam's advanced diagnostic capabilities for oncology, cardiology, and neurology. The technology improves disease visualization and clinical decision-making, encouraging greater investment in precision diagnostics and complementary laboratory testing services across the country.

Why Choose This Report?

• Provides a comprehensive overview of the overall market analysis, encompassing key trends, consumer behavior analysis, and risk assessment to support strategic decision-making.
• Provides accurate, up-to-date insights into market size, segmentation, and emerging opportunities, helping to minimize risk while capitalizing on growth.
• Gives deep understanding of target audience preferences, investment habits, and communication channels for enhanced product development and marketing effectiveness.
• Delivers competitive analysis and benchmarking, uncovering the strengths and weaknesses of market competitors to guide business strategies.
• Consolidates comprehensive market intelligence, reducing research efforts and streamlining strategic planning.
• Facilitates customized market segmentation and risk mitigation strategies, fine-tuned to specific business objectives.
• Aids in identifying both market challenges and untapped opportunities within the industry to drive long-term business growth.
• Provides valuable information based on actual customer data, industry developments, and search trends.